• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HAIR FOLLICLE TEST; ENZYME IMMUNOASSAY, AMPHETAMINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HAIR FOLLICLE TEST; ENZYME IMMUNOASSAY, AMPHETAMINE Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/23/2020
Event Type  malfunction  
Event Description
Drug testing; wellbutrin is showing a positive for methamphetamines' in my hair follicle tests.Wellbutrin showing positive for methamphetamine.Fda safety report id # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HAIR FOLLICLE TEST
Type of Device
ENZYME IMMUNOASSAY, AMPHETAMINE
MDR Report Key12954631
MDR Text Key281978279
Report NumberMW5105880
Device Sequence Number1
Product Code DKZ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 12/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/06/2021
Patient Sequence Number1
Treatment
PSEUDOEPHEDRINE; VYVANSE; WELLBUTRIN
Patient Outcome(s) Other;
Patient Age42 YR
Patient SexFemale
Patient Weight50 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-